The pathology of malignant melanoma

Dermatologic Clinics

Volumn 20, Issue 4, 2002, Pages 659-676

  Friedman, Robert J ^a   Heilman, Edward R ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CANCER STAGING; CELL PROLIFERATION; CELL SURFACE; DISEASE COURSE; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MELANOMA; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUNLIGHT; SURFACE PROPERTY; TUMOR GROWTH; VALIDATION PROCESS;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICROSCOPY, VIDEO; NEOPLASM STAGING; NEVUS, PIGMENTED; PHOTOMICROGRAPHY; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0036789167     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00041-4     Document Type: Review

References (29)

1. Clark Jr. WH, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 1969;29:705.
2. Clark Jr. WH, Goldman LI, Mastrangelo MJ. Human malignant melanoma. New York: Grune and Stratton; 1979.
3. Ackerman AB, Su WPD. The histology of cutaneous malignant melanoma. In: Kopf AW, et al, editors. Malignant melanoma. New York: Masson; 1979. p. 25.
4. Ackerman AB. Malignant melanoma: a unifying concept. Am J Dermatopathol 1980;2:309.
5. Elder DE, Jucovy PM, Tuthill RJ, et al. The classification of malignant melanoma. Am J Dermatopathol 1980;2:315.
6. Ackerman AB. Disagreements about classification of malignant melanoma. Am J Dermatopathol 1982;4:447.
7. Friedman RJ, Rigel DS, Kopf AW. Cancer of the skin. Philadelphia: WB Saunders; 1991.
8. Friedman RJ, Rigel DS, Heilman ER. The relationship between melanocytic nevi and malignant melanoma. Dermatol Clin 1988;6:249.
9. Kopf AW, Welkovich B, Frankel RE, et al. Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol 1987;13:345.
10. Clark Jr. WH. The development and biologic significance of neoplasia. The Lila Gruber Memorial Cancer Research Award. American Academy of Dermatology. Chicago, December, 1984.
11. Kraemer KH, Greene MH, Tarone R, et al. Dysplastic nevi and cutaneous melanoma risk. Lancet 1983; 2:1076.
12. Elder DE, Guery D, Epstein MN, et al. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol 1984;6:55.
13. Clark Jr. WH, Mastrangelo MJ, Ainsworth AM. Current concepts of the biology of human cutaneous malignant melanoma. Cancer Res 1977;242.
14. Elder DE, Guerry D, Clark Jr. WH. Early (radial growth phase) melanomas are biologically benign and share immunohistochemical markers with nevi. In: Proceedings of the International Pigment Cell Society. Tucson: 1986.
15. Friedman RJ, Rigel DS, Kopf AW, et al. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. Arch Dermatol 1983;119:455.
16. Sober AJ, Day CL, Fitzpatrick TB, et al. Early death from clinical stage I melanoma. J Invest Dermatol 1983;80(suppl 6):505.
17. Clark Jr. WH, Elder DE, Guerry D, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanomas. Hum Pathol 1984; 15:1147.
18. Herlyn M, Thurin J, Balaban G, et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985;45:5670.
19. Herlyn M, Thurin J, Balaban G, et al. Cell biology of melanoma and non-melanoma melanocytic lesions. In: Elder DE, editor. Pathobiology of malignant melanoma. Basel: Karger; 1987. p. 166.
20. Heenan PJ, Holman CDJ. Modular malignant melanoma: a distinct entity or a common end stage? Am J Dermatopathol 1982;4:477.
21. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971;28:914.
22. Breslow A. Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;179:902.
23. Schmoekel C, Nejad KK, Braun-Falco O. Malignant melanomas with high and low risk. In: Ackerman AB, editor. Pathology of malignant melanoma. New York: Masson; 1982. p. 321.
24. Rigel DS, Friedman RJ. Malignant melanoma. In: Stone J, editor. Dermatologic allergy and immunology. St Louis: CV Mosby; 1984.
25. Day Jr. CL, Harrist TJ, Gorstein F, et al. Malignant melanoma: prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 1981;194:108.
26. Lopransi S, Mihm Jr. MD. Clinical and pathologic correlation of malignant melanoma. J Cutan Pathol 1979;6:180.
27. Friedman RJ, Rigel DS. The clinical features of malignant melanoma. Dermatol Clin 1985;3:271.
28. Kamino H, Ackerman AB. Malignant melanoma in situ: the evolution of malignant melanoma within the epidermis. In: Ackerman AB, editor. Pathology of malignant melanoma. New York: Mason Publishing; 1981. p. 59.
29. Maize JC, Ackerman AB. Malignant melanoma. In: Maize JC, Ackerman AB, editors. Pigmented lesions of the skin. Philadelphia: Lea and Febiger; 1987. p. 165.